Free Newsletter
NJ puts $150M stem cell research center on hold
New Jersey's planned $150 million stem cell research center has been put on ice as state leaders ponder how to proceed in the wake of voters' rejection of a $450 million stem cell initiative last year. According to the Star-Ledger, state officials had earlier insisted that they would go ahead and complete construction of the 18-story facility. But Governor Jon Corzine told reporters that the state's once ambitious plans for stem cell research are on hold until officials get a better assessment of their options.
"I'd like to have a director and I'd like to see what our options are on making sure that New Jersey continues to be the leader, or among the leaders on biotech research--particularly as it relates to stem cells," Corzine said. "And then we'll work together on our rollout of what our plans are."
- read the story in the Star-Ledger
Related Articles:
NJ officials want to expand biopharma biz
NJ stem cell initiative shot down at the polls
NJ lawmakers back $270M stem cell program
In New Jersey, biotech industry is booming
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage


